William L. Current
General Counsel at Apexian Pharmaceuticals, Inc.
Profile
William L.
Current is currently the Vice President-Regulatory Affairs at Apexian Pharmaceuticals, Inc. He previously worked as the Vice President-Regulatory Affairs at Targanta Therapeutics Corp.
Dr. Current holds a doctorate degree from the University of Nebraska, an undergraduate degree from New Mexico State University, and a graduate degree from Washington State University.
William L. Current active positions
Companies | Position | Start |
---|---|---|
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | General Counsel | 2014-11-30 |
Former positions of William L. Current
Companies | Position | End |
---|---|---|
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | General Counsel | - |
Training of William L. Current
New Mexico State University | Undergraduate Degree |
Washington State University | Graduate Degree |
University of Nebraska | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |
- Stock Market
- Insiders
- William L. Current